新闻中心
内毒素检测新闻中心
新闻中心
科德角国际新闻中心
当前位置:
首页
>
>
>
Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens

Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens

  • 分类:文献资讯
  • 作者:
  • 来源:ScienceDirect
  • 发布时间:2022-01-26 13:37
  • 访问量:

【概要描述】Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens

Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens

【概要描述】Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens

  • 分类:文献资讯
  • 作者:
  • 来源:ScienceDirect
  • 发布时间:2022-01-26 13:37
  • 访问量:
详情

Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens

Highlights

  • SAM vaccines were engineered to express prototype bacterial antigens from GAS and GBS.
  • Mice immunized with both vaccines produced fully functional serum antibodies.
  • Antibodies elicited by SAM vaccines conferred protection in mouse infection models.
  • SAM vaccines have the potential to be used for a broad range of targets.

Abstract

Nucleic acid vaccines represent an attractive approach to vaccination, combining the positive attributes of both viral vectors and live-attenuated vaccines, without the inherent limitations of each technology. We have developed a novel technology, the Self-Amplifying mRNA (SAM) platform, which is based on the synthesis of self-amplifying mRNA formulated and delivered as a vaccine. SAM vaccines have been shown to stimulate robust innate and adaptive immune responses in small animals and non-human primates against a variety of viral antigens, thus representing a safe and versatile tool against viral infections. To assess whether the SAM technology could be used for a broader range of targets, we investigated the immunogenicity and efficacy of SAM vaccines expressing antigens from Group A (GAS) and Group B (GBS) Streptococci, as models of bacterial pathogens. Two prototype bacterial antigens (the double-mutated GAS Streptolysin-O (SLOdm) and the GBS pilus 2a backbone protein (BP-2a)) were successfully expressed by SAM vectors. Mice immunized with both vaccines produced significant amounts of fully functional serum antibodies. The antibody responses generated by SAM vaccines were capable of conferring consistent protection in murine models of GAS and GBS infections. Inclusion of a eukaryotic secretion signal or boosting with the recombinant protein resulted in higher specific-antibody levels and protection. Our results support the concept of using SAM vaccines as potential solution for a wide range of both viral and bacterial pathogens, due to the versatility of the manufacturing processes and the broad spectrum of elicited protective immune response.

扫二维码用手机看

相关资讯

暂时没有内容信息显示
请先在网站后台添加数据记录。

相关产品

暂时没有内容信息显示
请先在网站后台添加数据记录。

相关文件

  • Immunogenicity-and-protective-efficacy-induced-by-self-amplifying-_2017_Vacc.pdf

    大小:
    2022-01-26 13:37:18
  • Immunogenicity-and-protective-efficacy-of-a-single-dose-live-non-pat_2017_Va.pdf

    大小:
    2022-01-26 13:37:17
上一页
1

资讯推荐

产品推荐

细菌内毒素定量检测系统_PKF96
细菌内毒素定量检测系统_PKF96
Pyros Kinetix® Flex是一款新型细菌内毒素定量检测系统,适用于基因重组法/动态显色法/动态浊度法细菌内毒素检测实验,仪器包括32, 64, 96孔三种型号,符合USP,EP,JP细菌内毒素检测标准。
细菌内毒素&葡聚糖检测分析软件_Pyros®eXpress
细菌内毒素&葡聚糖检测分析软件_Pyros®eXpress
美国ACC公司推出的新一代细菌内毒素和葡聚糖检测分析软件,为您的定量内毒素和葡聚糖检测测试、报告需求、趋势和数据管理提供集成解决方案。
基因重组鲎试剂_PNG050-2
基因重组鲎试剂_PNG050-2
PyroSmart NextGenTM(PSNG)基因重组鲎试剂是一种基因工程合成的细菌内毒素定量检测试剂,不依赖天然鲎血,满足可持续发展的目标,可以应用动态显色法进行测试和分析。
显色法鲎试剂_CG1500
显色法鲎试剂_CG1500
细菌内毒素检测显色法试剂盒是一款多功能高灵敏度的细菌内毒素检测试剂,可用于动态显色法检测和终点显色法检测
浊度法鲎试剂_T0051
浊度法鲎试剂_T0051
Pyrotell®-T浊度法鲎试剂是一款定量检测细菌内毒素的产品,配合专用仪器(如PKF32/64/96)可用于动态浊度法及终点浊度法的内毒素检测实验。该产品已获得美国FDA认证

底部联系方式信息(左)

发布时间:2022-01-27 11:34:07

 

400-687-1881

公司电话:010-87875910

投诉热线:400-687-1881转8031

公司邮箱:info@bio-life.cn

公司官网:www.acciusa.cn  www.bio-life.cn

公司地址:北京市大兴区中关村科技园区大兴生物

医药产业基地华佗路50号院18幢(中国药谷CBP)

这是描述信息

关注官方微信

这是描述信息

关注手机网站